| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/13/2000 | CA2345729A1 Pharmaceutical compositions containing paclitaxel |
| 04/13/2000 | CA2345642A1 Methods for the treatment of non-thyroid disorders |
| 04/13/2000 | CA2345580A1 Photosensitizers for photodynamic applications |
| 04/13/2000 | CA2345477A1 Peptides related to an igf-ii-r epitope, polynucleotides encoding the peptides, and their use in immunomodulation |
| 04/13/2000 | CA2345440A1 Genes differentially expressed in cancer cells to design cancer vaccines |
| 04/13/2000 | CA2345408A1 Removal of preexisting antibodies to enhance the effectiveness of a therapeutic viral immunogenic agent |
| 04/13/2000 | CA2345377A1 Novel secreted proteins and polynucleotides encoding them |
| 04/13/2000 | CA2345375A1 Chemical structure with affinity for a phospholipid, and marker compound, diagnosis kit, and medicine comprising said structure |
| 04/13/2000 | CA2345240A1 Biodegradable terephthalate polyester-poly(phosphonate) and polyester-poly(phosphite) compositions, articles, and methods of using them |
| 04/13/2000 | CA2345209A1 Antisense modulation of integrin .alpha.4 expression |
| 04/13/2000 | CA2345133A1 Naphthalenecarboxamides as tachykinin receptor antagonists |
| 04/13/2000 | CA2345045A1 G-protein coupled receptor proteins |
| 04/13/2000 | CA2345000A1 A novel method of diagnosing, monitoring, staging, imaging and treating gastrointestinal cancers |
| 04/13/2000 | CA2344995A1 Cancer associated antigens and uses therefor |
| 04/13/2000 | CA2344973A1 Oxidoreductase molecules |
| 04/13/2000 | CA2344807A1 Naphthalenecarboxamides as tachykinin receptor antagonists |
| 04/13/2000 | CA2344613A1 Compositions and methods for inhibiting angiogenesis |
| 04/13/2000 | CA2341374A1 Quinoline and quinazoline derivatives and their use as inhibitors of cytokine mediated diseases |
| 04/13/2000 | CA2341351A1 Alpha-2/delta gene |
| 04/13/2000 | CA2341346A1 Non-peptide gnrh agents, methods and intermediates for their preparation |
| 04/13/2000 | CA2313169A1 Engraftable neural progenitor and stem cells for brain tumor therapy |
| 04/12/2000 | EP0992584A2 Purified mammalian FLT3 ligands and agonists and antagonists thereof |
| 04/12/2000 | EP0992579A1 Stem cell factor |
| 04/12/2000 | EP0991770A2 Prostate cancer gene |
| 04/12/2000 | EP0991760A1 Tumor growth inhibition- and apoptosis-associated genes and polypeptides and methods of use thereof |
| 04/12/2000 | EP0991757A1 Novel tumor antigens |
| 04/12/2000 | EP0991755A1 Oligonucleotide mediated specific cytokine induction and in vivo protection from infection |
| 04/12/2000 | EP0991661A2 Chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof |
| 04/12/2000 | EP0991658A1 Dolastatin 15 derivatives |
| 04/12/2000 | EP0991645A1 Bis-indole derivatives having antimetastatic activity, a process for their preparation and pharmaceutical compositions containing them |
| 04/12/2000 | EP0991644A1 Benzo(5,6)cycloheptapyridine cyclic ureas and lactams useful as farnesyl protein transferase inhibitors |
| 04/12/2000 | EP0991643A1 Novel aminooxyamide tricyclic inhibitors of farnesylprotein transferase |
| 04/12/2000 | EP0991637A1 Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives as farnesyl protein transferase inhibitors |
| 04/12/2000 | EP0991630A1 Crystalline roxifiban |
| 04/12/2000 | EP0991628A1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR P56?lck TYROSINE KINASES |
| 04/12/2000 | EP0991421A2 Detection and modulation of the iaps and naip for the diagnosis and treatment of proliferative disease |
| 04/12/2000 | EP0991417A1 Complex formation between dsdna and oligomer of heterocycles |
| 04/12/2000 | EP0991356A1 Device for projection mammography |
| 04/12/2000 | EP0814838A4 Antigen presenting system and methods for activation of t-cells |
| 04/12/2000 | EP0707566B1 Novel structural analogues of vitamin d |
| 04/12/2000 | EP0621270B1 Piperazine derivatives as collagenase inhibitors |
| 04/12/2000 | CN1250479A Modulators of the function of receptors of the TNF/NGF receptor family |
| 04/12/2000 | CN1250381A Remedies for lymphocytic tumors |
| 04/12/2000 | CN1249946A Chinese medicine composition for treating breast cancer and its preparation |
| 04/12/2000 | CN1249941A Oral Chinese medicine liquid for treating tumor |
| 04/12/2000 | CN1051315C Phosphonooxymethyl ethers of taxane derivatives |
| 04/12/2000 | CN1051310C Furyl or thienyl carbonyl substituted taxanes and pharmaceutical composition containing same |
| 04/12/2000 | CN1051309C Fluoro taxols |
| 04/12/2000 | CN1051306C Process for producing pyrrolopyrimidines and intermediates therefor |
| 04/12/2000 | CN1051232C Chinese traditional medicine pills for treating dysphagia |
| 04/11/2000 | US6048970 Prostate growth-associated membrane proteins |
| 04/11/2000 | US6048965 Polypeptide that controls the premature degradation of transcripts |
| 04/11/2000 | US6048897 Lipoxin compounds and their use in treating cell proliferative disorders |
| 04/11/2000 | US6048891 Administering mixtures with 6-hydroxy-2,7,8-trimethyl-chroman-2-propanoic acid for treatment of cardiovascular and kidney disorders |
| 04/11/2000 | US6048887 Substituted pyrroles |
| 04/11/2000 | US6048880 Therapy for cytokine sensitive diseases |
| 04/11/2000 | US6048873 Skin disorders |
| 04/11/2000 | US6048870 Mannosidase inhibitor; immunostimulant |
| 04/11/2000 | US6048869 Reductase inhibitors |
| 04/11/2000 | US6048868 Melatonin-antagonist β-carboline derivatives and analogues thereof containing naphthalenic structure, process for their preparation and their use as medicinal products |
| 04/11/2000 | US6048867 Biologically active rupununines |
| 04/11/2000 | US6048866 Substituted 2-anilinopryimidines useful as protein kinase inhibitors |
| 04/11/2000 | US6048849 Mixture of hormone or hormone inhibitor and sulfur containing compound |
| 04/11/2000 | US6048844 Treatment of conditions and disease |
| 04/11/2000 | US6048528 Monoclonal antibody for diagnostic and therapeutic use in ovarian cancer |
| 04/11/2000 | US6048523 Polyester cyclic compounds, their complexes and bonded bodies |
| 04/11/2000 | CA1340955C Stilbene derivatives |
| 04/06/2000 | WO2000019206A1 Ykl-40 as a marker and prognostic indicator for cancers |
| 04/06/2000 | WO2000018961A2 Expression analysis of specific nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 04/06/2000 | WO2000018959A1 Trex, a novel gene of traf-interacting ext gene family and diagnostic and therapeutic uses thereof |
| 04/06/2000 | WO2000018933A1 Immunotherapy of cancer through expression of truncated tumor or tumor-associated antigen |
| 04/06/2000 | WO2000018932A2 Receptor based antagonists and methods of making and using |
| 04/06/2000 | WO2000018919A1 Human kinesin-like motor protein |
| 04/06/2000 | WO2000018915A2 Membrane-associated organizational proteins |
| 04/06/2000 | WO2000018914A2 Novel dkr polypeptides |
| 04/06/2000 | WO2000018895A1 Short peptides which selectively modulate the activity of protein kinases |
| 04/06/2000 | WO2000018888A1 Immunomodulation by genetic modification of dendritic cells and b-cells |
| 04/06/2000 | WO2000018885A1 Methods of controlling proliferation and differentiation of stem and progenitor cells |
| 04/06/2000 | WO2000018821A1 Biodegradable low molecular weight triblock polyester polyethylene glycol copolymers having reverse thermal gelation properties |
| 04/06/2000 | WO2000018803A2 Antibodies to mammalian langerhans cell antigen and their uses |
| 04/06/2000 | WO2000018799A1 Artemin, a novel neurotrophic factor |
| 04/06/2000 | WO2000018796A2 Secretory protein- zsig48 |
| 04/06/2000 | WO2000018795A2 Compositions and methods for wt1 specific immunotherapy |
| 04/06/2000 | WO2000018781A1 Antisense modulation of survivin expression |
| 04/06/2000 | WO2000018764A1 Benzimidazolinyl piperidines as cgrp ligands |
| 04/06/2000 | WO2000018761A1 Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors |
| 04/06/2000 | WO2000018753A1 2-phenylpyran-4-one derivatives |
| 04/06/2000 | WO2000018744A1 Oxazole compounds as prostaglandin e2 agonists or antagonists |
| 04/06/2000 | WO2000018740A1 Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors |
| 04/06/2000 | WO2000018738A1 Benzamide derivatives and their use as cytokine inhibitors |
| 04/06/2000 | WO2000018734A1 Novel substituted indolinones with an inhibitory effect on various kinases and cyclin/cdk complexes |
| 04/06/2000 | WO2000018440A1 Somatostatin receptor radioligand with increased uptake |
| 04/06/2000 | WO2000018439A2 Use of neoangiogenesis markers for diagnosing and treating tumours by therapy |
| 04/06/2000 | WO2000018437A1 Tie2 antagonist antibodies |
| 04/06/2000 | WO2000018435A1 Time-staggered utilization of tumor cells in combination with intact antibodies for immunization |
| 04/06/2000 | WO2000018423A1 Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of lh-rh analogues |
| 04/06/2000 | WO2000018421A1 Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
| 04/06/2000 | WO2000018398A1 Pharmaceutically active compounds and methods of use thereof |
| 04/06/2000 | WO2000018397A1 Compounds for the treatment of estrogen-dependent illnesses and methods for making and using the same |
| 04/06/2000 | WO2000018393A1 Chemotherapy of cancer with acetyldinaline in combination with gemcitabine, capecitabine or cisplatin |